Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota

Xiaoyan Zhang,Sha Chen,Feipeng Duan,An Liu,Shaojing Li,Wen Zhong,Wei Sheng,Jun Chen,Jiang Xu,Shuiming Xiao
DOI: https://doi.org/10.1016/j.jgr.2020.08.001
IF: 5.735
2021-03-01
Journal of Ginseng Research
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Gut microbiota mainly function in the biotransformation of primary ginsenosides into bioactive metabolites. Herein, we investigated the effects of three prebiotic fibers by targeting gut microbiota on the metabolism of ginsenoside Rb1 <em>in vivo</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Sprague Dawley rats were administered with ginsenoside Rb1 after a two-week prebiotic intervention of fructooligosaccharide, galactooligosaccharide, and fibersol-2, respectively. Pharmacokinetic analysis of ginsenoside Rb1 and its metabolites was performed, whilst the microbial composition and metabolic function of gut microbiota were examined by 16S rRNA gene amplicon and metagenomic shotgun sequencing.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The results showed that peak plasma concentration and area under concentration time curve of ginsenoside Rb1 and its intermediate metabolites, ginsenoside Rd, F2, and compound K (CK), in the prebiotic intervention groups were increased at various degrees compared with those in the control group. Gut microbiota dramatically responded to the prebiotic treatment at both taxonomical and functional levels. The abundance of <em>Prevotella</em>, which possesses potential function to hydrolyze ginsenoside Rb1 into CK, was significantly elevated in the three prebiotic groups (P&lt;0.05). The gut metagenomic analysis also revealed the functional gene enrichment for terpenoid/polyketide metabolism, glycolysis, gluconeogenesis, propanoate metabolism, etc.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>These findings imply that prebiotics may selectively promote the proliferation of certain bacterial stains with glycoside hydrolysis capacity, thereby, subsequently improving the biotransformation and bioavailability of primary ginsenosides <em>in vivo</em>.</p>
chemistry, medicinal,integrative & complementary medicine
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to enhance the biotransformation and bioavailability of ginsenosides in rats by modulating the gut microbiota. Specifically, the study focused on the effects of three prebiotic fibers (fructooligosaccharide FOS, galactooligosaccharide GOS, and Fibersol - 2) on the pharmacokinetic characteristics of ginsenoside Rb1 and its metabolites, and how these prebiotic fibers change the composition and potential metabolic functions of the gut microbiota. ### Main research questions: 1. **Effects of prebiotic fibers on the pharmacokinetics of ginsenoside Rb1 and its metabolites**: - By orally administering prebiotic fibers (FOS, GOS, and Fibersol - 2) to rats, the researchers observed whether these prebiotic fibers could increase the plasma concentrations and pharmacokinetic parameters (such as AUC, Cmax, etc.) of ginsenoside Rb1 and its metabolites (such as Rd, F2, and compound K (CK)). 2. **Effects of prebiotic fibers on the structure and function of the gut microbiota**: - Through 16S rRNA gene amplicon sequencing and metagenomic sequencing, the researchers analyzed the changes in the composition and metabolic functions of the gut microbiota after prebiotic fiber intervention. Particular attention was paid to the abundance changes of certain specific genera (such as Prevotella) and their relationships with ginsenoside biotransformation. ### Research background: - Ginsenosides are the main active components of ginseng and have multiple pharmacological effects, but the oral bioavailability of their precursor compounds (such as Rb1) is low. - The gut microbiota plays a crucial role in the biotransformation of ginsenosides and can convert precursor compounds into more active secondary metabolites (such as compound K). - By modulating the gut microbiota, the bioavailability and pharmacological activity of ginsenosides can be improved. ### Research methods: - **Animal experiments**: Sprague Dawley rats were used and divided into a control group and three prebiotic fiber intervention groups (FOS, GOS, and Fibersol - 2). - **Pharmacokinetic analysis**: The plasma concentrations of ginsenoside Rb1 and its metabolites were determined by UPLC - ESI - QqQ - MS/MS technology, and the pharmacokinetic parameters were calculated. - **Gut microbiota analysis**: The composition and metabolic functions of the gut microbiota were analyzed by 16S rRNA gene amplicon sequencing and metagenomic sequencing. ### Research results: - Prebiotic fiber intervention significantly increased the plasma concentrations and AUC values of ginsenoside Rb1 and its metabolites (Rd, F2, and CK). - The composition and function of the gut microbiota changed significantly after prebiotic fiber intervention, especially the abundance of Prevotella increased significantly, which may be related to its ability to hydrolyze ginsenosides. - Metagenomic analysis showed that after prebiotic fiber intervention, the abundance of genes encoding enzymes related to carbohydrate metabolism (such as β - glucosidase) increased significantly. ### Conclusions: - Prebiotic fibers can improve the biotransformation and bioavailability of ginsenosides by selectively promoting the proliferation of specific bacteria with glycoside - hydrolyzing ability. - This finding provides a new strategy for improving the efficacy of oral drugs by modulating the gut microbiota.